申请人:AMGEN INC.
公开号:US20180177767A1
公开(公告)日:2018-06-28
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
本文提供了KRAS G12C抑制剂,其组成,以及使用方法。这些抑制剂对治疗多种疾病有用,包括胰腺癌、结直肠癌和肺癌。